Eight enteric-coated 50 mg diclofenac sodium tablet formulations marketed in Saudi Arabia: in vitro quality evaluation

OBJECTIVE: To evaluate in vitro quality of enteric-coated 50 mg diclofenac sodium tablet formulations on Saudi market. RESULTS: A reference and seven generic (G1-7) formulations were commercially available in December 2019/January 2020 and were assessed within 25–75% of manufacture-expiration period...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammami, Muhammad M., Hussein, Rajaa F., AlSwayeh, Reem, Alvi, Syed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491129/
https://www.ncbi.nlm.nih.gov/pubmed/32928294
http://dx.doi.org/10.1186/s13104-020-05270-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491129/
https://www.ncbi.nlm.nih.gov/pubmed/32928294
http://dx.doi.org/10.1186/s13104-020-05270-4

Ejemplares similares